Preparation and Characterization of Atenolol Laden Nanoparticles

D. Archana, J. Divya
{"title":"Preparation and Characterization of Atenolol Laden Nanoparticles","authors":"D. Archana, J. Divya","doi":"10.15406/JNMR.2016.04.00084","DOIUrl":null,"url":null,"abstract":"In the present study, an attempt was made to develop nanoparticles of Atenolol for effective treatment of Glaucoma. By developing the nanoparticulated delivery the required action of drug at the target site i.e. at eye can be provided. The nanoparticles were prepared by nano precipitation method. The formulation was subjected to different evaluation parameters like particle size, zeta potential, drug content uniformity, entrapment efficiency, in-vitro drug release study.                \n \n The particle size range of nanoparticles was found to be 100-256 nm. The zeta potential of nanoparticles was found to be 55.87 to 64.87 mV. The drug content of different formulations F1 to F8 was calculated and the content was found to be in range of 95.98 TO 102.14 %. The entrapment efficiency was found to be in range of 45.76 to 72.98%. From the in-vitro drug release studies, it was found that the cumulative percent drug release for optimised formulation F5 found to be between 12.56 to 88.15 % respectively.","PeriodicalId":16465,"journal":{"name":"Journal of Nanomedicine Research","volume":"11 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nanomedicine Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/JNMR.2016.04.00084","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

In the present study, an attempt was made to develop nanoparticles of Atenolol for effective treatment of Glaucoma. By developing the nanoparticulated delivery the required action of drug at the target site i.e. at eye can be provided. The nanoparticles were prepared by nano precipitation method. The formulation was subjected to different evaluation parameters like particle size, zeta potential, drug content uniformity, entrapment efficiency, in-vitro drug release study.                The particle size range of nanoparticles was found to be 100-256 nm. The zeta potential of nanoparticles was found to be 55.87 to 64.87 mV. The drug content of different formulations F1 to F8 was calculated and the content was found to be in range of 95.98 TO 102.14 %. The entrapment efficiency was found to be in range of 45.76 to 72.98%. From the in-vitro drug release studies, it was found that the cumulative percent drug release for optimised formulation F5 found to be between 12.56 to 88.15 % respectively.
负载阿替洛尔纳米颗粒的制备与表征
在本研究中,我们试图开发纳米阿替洛尔,以有效治疗青光眼。通过开发纳米关节递送,可以提供药物在目标部位(即眼睛)所需的作用。采用纳米沉淀法制备纳米颗粒。对该制剂进行了粒径、zeta电位、药物含量均匀性、包封效率、体外释药等评价参数的研究。纳米颗粒的粒径范围为100 ~ 256 nm。纳米粒子的zeta电位为55.87 ~ 64.87 mV。计算了不同配方F1 ~ F8的药物含量,其含量范围为95.98 ~ 102.14%。捕集率为45.76 ~ 72.98%。体外释药研究发现,优化后的F5的累积释药率分别在12.56% ~ 88.15%之间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信